Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens

Science of the Total Environment

Volumn 248, Issue 1, 2000, Pages 51-62

  Payne, J ^a   Jones, C ^b   Lakhani, S ^b   Kortenkamp, A ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

CGH; MCF 7; Xenoestrogen

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; HEXACHLOROCYCLOHEXANE;

ARTICLE; CELL COUNT; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; DRUG SENSITIVITY; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; SCREENING; STRAIN DIFFERENCE; TECHNIQUE;

CELL DIVISION; CYTOGENETICS; DDT; DICHLORODIPHENYL DICHLOROETHYLENE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HUMANS; LINDANE; NUCLEIC ACID HYBRIDIZATION; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED; XENOBIOTICS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034728669     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0048-9697(99)00479-9     Document Type: Article

References (25)

1. Andersen H., Andersson A., Arnold S. et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect. 107(Supp 1):1999;89-108.
2. Berthois Y., Katzenellenbogen J., Katzenellenbogen B. Phenol red in tissue culture media is a weak oestrogen: implications concerning the study of oestrogen-responsive cells in culture. Proc Natl Acad Sci USA. 83:1986;2496-2500.
3. Bitman J., Cecil H., Harris, Fries G. Estrogenic activity of o,p′-DDT in the mammalian uterus and avian oviduct. Science. 162:1968;371-372.
4. Burrow M., Weldon C., Tang Y. et al. Differences in susceptibility to tumour necrosis factor α-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 58:1998;4940-4946.
5. Colborn T., vom Saal F., Soto A. Developmental effect of endocrine disrupting chemicals in wildlife and humans. Environ Health Perspect. 101:1993;378-385.
6. Forman D., Moller H. Testicular cancer. Cancer Surv. 19/20:1994;323-341.
7. Jones P., Barker V., Irwin A., Earl L. Modulation of MCF-7 cell proliferative responses by manipulation of assay conditions. Toxicol In Vitro. 11:1997;769-773.
8. Kallioneimi A., Kallioneimi O., Sudar D. et al. Comparative genomic hybridisation for molecular cytogenetic analysis of solid tumours. Science. 258:1992;818-821.
9. Katzenellenbogen J. The structural pervasiveness of estrogenic activity. Environ Health Perspect. 103(Suppl 7):1995;99-101.
10. Katzenellenbogen B., Kendra K., Norman M., Berthois Y. Proliferation, hormonal responsiveness, and oestrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 47:1987;4355-4360.
11. Kelce W., Stone C., Laws S., Gray L., Kemppainen J., Wilson E. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature. 375:1995;581-583.
12. Klotz D., Beckman B., Hill S., McLachlan J., Walters M., Arnold S. Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ Health Perspect. 104:1996;1084-1089.
13. Olea N., Pulgar R., Prerez P. et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect. 104:1996;298-305.
14. Sharpe R., Skakkebaek N. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 341:1993;1392-1395.
15. Skehan P., Storeng R., Scudiero D. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 82:1990;1107-1112.
16. Soto A., Sonnenschein C., Chung K., Fernandez M., Olea N., Olea Serrano F. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 103(Suppl 7):1995;113-122.
17. Soto A., Fernandez M., Luizzi M., Oles Karasko A., Sonnenschein C. Developing a marker of exposure to xenoestrogen mixtures in human serum. Environ Health Perspect. 105(Suppl 3):1997;647-654.
18. Soule H., Vazquez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 51:1973;1409-1413.
19. Steinmetz R., Young P., Caperell-Grant A. et al. Novel estrogenic action of the pesticide residue ß-hexachlorocyclohexane in human breast cancer cells. Cancer Res. 56:1996;5403-5409.
20. Tirkkonen M., Tanner M., Karhu R., Kallioneimi A., Isola J., Kallioneimi O. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer. 21:1998;177-184.
21. Villalobos M., Olea N., Brotons J., Olea Serrano M., Ruiz de Almodovar J., Pedraza V. The E-Screen assay: a comparison of different MCF-7 cell stocks. Environ Health Perspect. 103:1995;844-850.
22. Wells D., Sherlock J., Handyside A., Delhanty J. Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genomic hybridisation. Nucleic Acids Res. 27:1999;1214-1218.
23. Wolff M., Weston A. Breast cancer risk and environmental exposure. Environ Health Perspect. 105(Suppl 4):1997;891-896.
24. Zacharewski T. In vitro bioassays for assessing estrogenic substances. Environ Sci Technol. 31:1997;613-623.
25. Zava D., Blen M., Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect. 105(Suppl 3):1997;637-645.